Literature DB >> 6389825

Microbial kinetics of beta-lactam antibiotics against Escherichia coli.

A Tsuji, S Hamano, T Asano, E Nakashima, T Yamana, S Mitsuhashi.   

Abstract

Microbial kinetics of Escherichia coli NIHJ JC-2 and E. coli B/r were investigated in the presence of beta-lactam antibiotics. To maintain a constant drug concentration during the experiment, a novel technique, using a dialysis membrane tube containing the drug solution, was successfully employed. The drug-affected generation curves of E. coli exhibited common features. After the addition of drug, an apparent lag period was noted, followed by a first-order decrease of the sensitive organisms and, 6 h later, by a regrowth of resistant organisms, depending on the antibiotic concentration used. The relationship between the apparent generation rate constant, kapp, and the antibiotic concentration was found to be nonlinear. This phenomenon is consistent with a saturable receptor site model for the drug action. A good linear free energy relationship was observed between the microbial kinetic parameter, kmax, and the alkaline degradation rate constants, kOH, of the cephalosporins studied.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6389825     DOI: 10.1002/jps.2600731024

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

Review 1.  Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.

Authors:  R C Li; M Zhu; J J Schentag
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

2.  Simultaneous pharmacodynamic analysis of the lag and bactericidal phases exhibited by beta-lactams against Escherichia coli.

Authors:  R C Li
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

3.  Antibiotic exposure and its relationship to postantibiotic effect and bactericidal activity: constant versus exponentially decreasing tobramycin concentrations against Pseudomonas aeruginosa.

Authors:  R C Li; Z Y Zhu; S W Lee; K Raymond; J M Ling; A F Cheng
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

4.  Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due to Pseudomonas aeruginosa.

Authors:  J G Zhi; C H Nightingale; R Quintiliani
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

5.  The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactions.

Authors:  R C Li; J J Schentag; D E Nix
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

6.  Application of mathematical model to experimental chemotherapy of fatal murine pneumonia.

Authors:  T Hishikawa; T Kusunoki; K Tsuchiya; Y Uzuka; T Sakamoto; T Nagatake; K Matsumoto
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

7.  New turbidimetric assay for quantitation of viable bacterial densities.

Authors:  R C Li; D E Nix; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.